Medications, including some created to treat diabetes, are becoming increasingly popular for their ability to support weight loss.

Among these are several drugs that belong to a class known as GLP-1 receptor agonists. While they share similarities, there are differences, particularly in the drugs semaglutide and tirzepatide.

Semaglutide, the active ingredient in Ozempic and Wegovy,........

© The Hill